Evidence map›Paper›PMID 40971743›Full record

ReviewNeurology2025

Gait Analysis in Neurologic Disorders: Methodology, Applications, and Clinical Considerations.

Farwa Ali, Hannah Padilla, Audrey M Blazek, Leland Barnard, Kenton R Kaufman

Abstract readReview
In one paragraph

Review in Neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Walking as a Window to the Brain: Redefining Gait in Neurology.Medical sciences (Basel, Switzerland) · 2026
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Farwa AliDepartment of Neurology, Mayo Clinic, Rochester, MN.ORCID 0000-0001-6060-3995
Hannah PadillaMayo Medical School, Rochester, MN; and.
Audrey M BlazekDepartment of Neurology, Mayo Clinic, Rochester, MN.ORCID 0000-0003-4096-7825
Leland BarnardDepartment of Neurology, Mayo Clinic, Rochester, MN.ORCID 0000-0003-1569-9312
Kenton R KaufmanDepartment of Orthopedic Surgery, Mayo Clinic, Rochester, MN.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gait and balance disorders are a leading cause of morbidity, mortality, and disability in central and peripheral neurologic disorders. Neurologic gait disorders are classically evaluated with a clinical examination and visual pattern recognition. Gait patterns such as a parkinsonian or ataxic gait may have distinct etiologies and are assessed using the neurologic physical examination and validated clinical scales. Technological advances have made gait analysis more accessible, allowing precise objective measurement of gait and balance deficits. Gait analysis may be more sensitive at detecting change compared with a physical examination alone. It has the potential to augment clinical diagnosis, track disease progression, and evaluate response to therapies in clinical trials. Additional applications of gait analysis include early disease screening, discriminating between conditions that have similar gait profiles, and use of quantified gait parameters to predict future outcomes. Numerous devices are now available to conduct gait performance measurements in the laboratory, clinic, or real-world settings. With the rapid growth of gait analysis technology and application of artificial intelligence to these data, there are clinical and research implications that should be carefully considered when evaluating patients with neurologic disorders. Important factors include the clinical or research question, reliability and validity of the method used, and the effect of environmental and patient factors. Knowledge of gait analysis technology is essential for clinicians to implement this tool in clinical practice or research and critically analyze literature on the topic in neurologic diseases. In this narrative review, we provide an overview of normal gait function, an appraisal of available gait analysis technologies (merits and applications), implications for clinicians and researchers, recent advances in gait analysis for neurologic disorders, and future considerations.

Indexed as

Gait AnalysisGait Disorders, NeurologicNervous System DiseasesGaitHumans

Identifiers

PMID40971743
PMCPMC12459283

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.